Retatrutide is a groundbreaking pharmaceutical being investigated as a potential treatment for type 2 diabetes. This novel approach belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor https://mediajx.com/story26817907/retatrutide-a-new-treatment-for-type-2-diabetes